- Revised FY2027 sales guidance to $1.825B–$1.875B (from $1.80B–$1.85B)
- Raised FY2027 Adj. Diluted EPS to $7.00–$7.30 (from $6.75–$7.15) and Adj. EBITDA to $380M–$420M
- $20M shares repurchased YTD with ~$113M remaining authorization, leverage at 1.3x
?? Positive AI Sentiment (+6.5 / 10)